SCHEMBL4201641

SCHEMBL4201641

CCCCCCC(CCCCCCCCCCC(=O)O)OC(=O)CC.CCCCCCC(O)CCCCCCCCCCC(=O)O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 3/20 0.71
FFAR1 O14842 3/20 0.71
FAAH O00519 1/20 0.51
GPR84 Q9NQS5 9/20 0.50
PPARG P37231 6/20 0.50
PPARD Q03181 6/20 0.50
PPARA Q07869 6/20 0.50
HDAC11 Q96DB2 5/20 0.50
TSHR P16473 4/20 0.50
ALDH1A1 P00352 2/20 0.50
TLR2 O60603 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
FABP4 P15090 2/20 0.50
PTPN1 P18031 2/20 0.50
SLC22A6 Q4U2R8 1/20 0.50
SLC22A8 Q8TCC7 1/20 0.50
MEN1 O00255 1/20 0.50
ESR1 P03372 1/20 0.50
ALOX15 P16050 1/20 0.50
PDE4A P27815 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4204493 0.94 FFAR4 (0.59) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL15692650 0.93 FFAR4 (0.73) FFAR4FFAR1FAAHGPR84PPARG
SCHEMBL1134727 0.93 FFAR4 (0.73) FFAR4FFAR1FAAHGPR84PPARG
SCHEMBL4201646 0.91 MAPK1 (0.58) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL29160513 0.90 FFAR4 (0.69) FFAR4FFAR1FAAHGPR84TSHR
SCHEMBL29175263 0.90 FFAR4 (0.68) FFAR4FFAR1FAAHGPR84TSHR
SCHEMBL27949697 0.89 FFAR4 (0.50) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL3403797 0.88 FFAR4 (0.66) FFAR4FFAR1FAAHGPR84PPARG
SCHEMBL10695256 0.88 FFAR4 (0.66) FFAR4FFAR1FAAHGPR84TSHR
SCHEMBL5972507 0.86 FFAR4 (0.63) FFAR4FFAR1TSHRALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7491836-B2 Non-ionic surfactants for poorly soluble molecules ASTRAZENECA AB (SE) 2009-02-17 US disclosed
US-20060287542-A1 Non-ionic surfactants for solubilizing poorly solubule molecules ASTRAZENECA AB (SE) 2006-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060287542-A1 Non-ionic surfactants for solubilizing poorly solubule molecules LIPA, ELOVL1, FASN FFAR4 137/4885FFAR1 29/4885FAAH 40/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.